Reddit Posts
Does deep ITM options near expiration lose liquidity frequently?
COVID rampage likely shrank China's population again in 2023
Reminder that if you are a PTON, NVO, or LLY bull you have a duty as a shareholder to demotivate all the new people at the gym
$KO outperforms half of the Mag 7 in 2024 because of $NVO and $LLY
Was very bullish on PNT. Yet the stock fell 11% after not bad news about the trial.
Will the Eli Lilly buyout of Point Biopharma actually go through???
Microcap Offers Unique Opportunity for Investors In $10 Billion SCI Industry (TSXV: NRX, FSE: J90, NRX.V)
How the big boys (may or may not) alter CPI
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says
Extremely bullish for $LLY as their drugs will literally solve obesity based pay disparity- lmfao what an article. Thank you Economist
Since December 22, 2015, Jim Cramer was always bullish on Eli Lilly (closed at $73.39 div-adjusted). Today, the stock is trading at $591.71
$LLY yolo update - I’m still holding and loving the LLY bears. Today was a swing from down $7K to up $7K
Why wouldn't you invest a large amount of money into Pfizer right now and ride it out for a few years?
Novo Nordisk Semaglutide/cardiovascular outcomes SELECT Trial Results (NVO + see also LLY)
LLY yolo update - over $200K in shares
Eli Lilly $LLY weight loss drug still needs a green-signal
Zepbound (tirzepatide) by LLY approved by FDA for weight loss.
Can someone please explain LLY business model?
Highly shorted biotech stocks like BEAM and DNA (Ginkgo Bioworks) getting squeezed right now
beat Cathie Wood at her own agme (kinda) crispr time is ripe folks
beat Cathie Wood at her own agme (kinda) crispr time is ripe folks
beat Cathie Wood at her own agme (kinda) crispr time is ripe folks
VERVE therepeutics potential for the next boom boom?
7 Diabetes and Weight Loss Drug Stocks With Big Potential
Wall Street hikes forecasts for anti-obesity drug sales to $100B and beyond.
Do brokers normally close options with market orders?
600p LLY…some dude said this was the next play
“Stocks don’t go up in a straight line” boomers have no clue how the new markets work.
Over $10K in gains thanks to the big homies using LLY to get skinny … thanks biggies!
NVO YOLO update - 21k to 70k. I sold some NVO and bought some LLY, details inside
LLY would be a good a idea to short LLY
What happened to Gilead, comparing to Eli LYLY
CDC: New Variant BA.2.86 More Capable of Causing Infection In Those Previously Vaccinated or Infected
LLY 1/24 calls. Does the stock chart suggest a double top?
Eli Lilly’s $LLY Alzheimer’s Drug Shows Promise in Latest Trial
Is there any benefit in investing In both Index ETF’s and individual stocks?
Is there any benefit in investing In both Index ETF’s and individual stocks?
Is there any benefit in investing In both Index ETF’s and individual stocks?
What are your thoughts about Weight Watchers (WW)? I prescribe weight loss medications, and they are very good. WW could be primed.
Rebalancing Dilemma: Should I Adjust My Portfolio Now?
People are so obsessed about Cramer's HD play, but it is up 1.5% since his recommendation!
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
🚀 YTD returns of 12.46% with Portfolio Visualizer, WSB! Let's Goooo! 🌙
TDOC, LLY, ROKU and CMCSA rises on earnings; DBX falls on layoffs; LUV, CAT and BMY slides
Lilly stock obesity therapy shows ~16% weight loss (NYSE:LLY)
What do you guys think about the high PEs of pharmaceuticals like NVO and LLY?
2023-04-21 Wrinkle Brain Plays - In the style of Madame Zeroni
Technical Trade Radar: April 10 - 14 (FDX, GIS, ICE, ORCL, CAH, LLY, PEP)
Kindly help me narrow down my healthcare stock picks (info in description)
California to produce state-label low-cost insulin (NYSE:LLY)
LLY stock upgraded at Wells Fargo citing opportunity after weakness (NYSE:LLY)
Mentions
Companies are literally curing cancer and still get their ass bombed. Just look at LLY, NVO, and PFE this year so far. Flat or down.
What are we thinking about $LLY earnings tomorrow?
LLY really limping into earnings tomorrow morning .. at this point it'll be feast or famine as I'm resigned to going down with the ship
I thought LLY was into Memory or was that menopause
Wheat futures broke put yesterday. 100% increase in nitrogen fertilizers prices will do that. Last time we lost 5% of production wheat prices went 50% up. A lot of people are about to get hungry and a lot thinner and a bunch of governmens will eat the dirt (remember the Arab Spring?). Calls $WEAT puts on $LLY
Wheat futures broke put yesterday. 100% increase in nitrogen fertilizers will do that. Last time we lost 5% of production prices went 50% up. A lot of people are about to get hungry and a lot thinner. Calls $WEAT puts on $LLY
nvo but no LLY? You can’t be serious here🤣
U gotta split NVO with LLY
Yes you can give someone enough amphetamines to make a 300 pound 13 yr old fat boy sit still. Or you can just buy LLY and wonder why no one has any idea what you're talking about anymore
Put $META, Put $MSFT, and Put $LLY
!banbet LLY to 900 in 15 days
!banbet LLY to 900 by May 8
LULU, and LLY are my worst plays this year so far, my god
Most recent ones was I added more LLY and MSFT. Early this year it was EMBJ, MELI and NFLX.
Sold a few MU and GOOGL, and moving a portion of profits to LLY. i'm a little concerned holding thru this round of earnings. It'll sit it as cash for now while keeping an eye for stocks the sold off after a great earnings.
What are people’s predictions for LLY before/after earnings? Is it more worth trying to buy in before the earnings or do we expect a big drop after?
Back into LLY and NFLX it looks like.
# Healthcare (7 stocks)Equal-weight: +1.31% |Ticker|Name|Dec 22, 2025|Apr 28, 2026|% Change|JPM Target| |:-|:-|:-|:-|:-|:-| |**BSX**|Boston Scientific Corporation|$96.43|$59.95|\-37.83%|$135.00| |**CVS**|CVS Health|$77.04|$78.36|\+1.71%|$101.00| |**FOLD**|Amicus Therapeutics|$14.21|$14.49|\+1.97%|$19.00| |**LLY**|Eli Lilly & Company|$1074.69|$868.27|\-19.21%|$1150.00| |**RVMD**|Revolution Medicines|$80.58|$131.67|\+63.40%|$92.00| |**TMO**|Thermo Fisher Scientific|$575.13|$468.04|\-18.62%|$675.00| |**XENE**|Xenon Pharmaceuticals|$46.08|$54.26|\+17.75%|$60.00| |**Category Average**|—|—|**+1.31%**|—|
# Healthcare |**Ticker**|**Dec 22, 2025 Price**|**Apr 28, 2026 Price**|**% Change**| |:-|:-|:-|:-| |**RVMD**|$82.10|$135.30|\+64.80%| |**FOLD**|$14.50|$18.20|\+25.52%| |**BSX**|$62.40|$75.10|\+20.35%| |**TMO**|$545.00|$592.40|\+8.70%| |**XENE**|$38.20|$45.60|\+19.37%| |**CVS**|$78.00|$77.94|\-0.08%| |**LLY**|$1,072.89|$868.27|\-19.07%| |**Category Average**|||**+17.08%**|
No LLY picked NOVO? You truly regraded
None of this matters, what matters is if Reta is classified as a biologic or not. If it is, LLY will be re-rated higher. If not, the growth story is more muted.
Brilliant play on both sides. I do think that 50% of it should be NVO + LLY though. That said, I love me some Wendy's burger and a chocolate frosty.
"both sides" = NVO vs every other fast food? at least add in LLY though LLY is worth more than this entire list combined
LLY and NVO coming to trim the fat
LLY was always the better pick, been calling trash since 120. If you wanna talk details dm me
Calls on LLY for $925 EOW?
Is LLY a buy before earnings?
anyone bought the LLY dip for earnings or meh?
Oh hell no, LLY about to tank, people would rather give up weight loss than sexy time especially if you in long term relationship ain’t no one trying to bag it for 3-6 months
Can fat people stop buying LLY puts though
No sex on LLY pill. NVO bull case?
It’s just math and I was just talking about stocks. And mentioned LLY as OP said it was an expensive backup.
LLY still bleeding while everything else pumps, tough week for healthcare
This is a valid point, but I would point out that there are other options. The younger person who is willing and able to seek medical solutions for convenience might very well have an IUD. She might also just choose to ignore the warning and go about her business - as I understand it, the birth control interaction is not confirmed, but is possible and hasn't been ruled out. I suspect it will come down to cost and side effects. No current position in either LLY or NVO.
#TLDR --- **Ticker:** NVO (Bearish on LLY) **Direction:** Up **Prognosis:** Long NVO Calls / Shares **Core Catalyst:** The desire to rawdog **Chief Friction Analysis:** LLY's weight loss pill requires 6 months of condoms for women on birth control, while Novo's doesn't. LLY is about to become the official sponsor of "sad-sausage-boyfriends."
Patiently waiting like an alpha male to buy this dip on LLY.
Alright so I'm up to a bunch of dips that I'm now eyeing up. AMTM, DE, some set of defense/aero names - GD/GE/TXT/NOX, dollar stores maybe DG/DLTR, LLY, and healthcare as well - THC/UHS. Gotta start picking between all these to slowly start adding positions lmao
Tried scalping LLY puts, mmmmmgay
Yes. This describes our strategy exactly. We invest small amounts in a number of promising companies and hold forever. In the long term a few do spectacularly well, while most don’t. But the ones that succeed grow so much in the long term that the others don’t matter that much. We currently have positions in about 80 companies. After a few decades, four companies—LLY (1984), AAPL (2005), LRCX (2011) and ROST (1988) total more than $20mm, with another five or so over one million, about 50 that grew a little, and 10 or so stinkers. IMO, that’s what a successful strategy looks like.
Need LLY to die so NVO can livr
ngl kinda scary semis up this much. im just holding on because my average is way below from the top and money printing will not stop soon. I'd be worried buying this high up though.. but i guess some metrics say they still fair valued. I might sell a few to add more LLY. if you believe in GLP-3, this might be something to look at.
LLY -4.5% sure why not
Is there anything more satisfying than scalping LLY every 3-4 months?
LLY is killing my port today 😢
Apparently LLY GLP-1 isn't that popular.
Jesus Christ, LLY dipped 4% this morning. What in the absolute fuck
LLY wants biologic status with the FDA for retatrutide so they get 12 years of regulatory exclusivity and compounding would be illegal. ✍️
I would say I had or have long term conviction in all of them, except LULU I bought that at the recommendation of a friend who works in IB so thought he couldn't be wrong. I actually did see it go over $400 at one point but since then it just keeps going lower. NVO I still have conviction in, I've seen how well GLP-1 works and that obesity is one of the biggest health issues in the U.S. however I also know LLY has the home field advantage, but still believe the Ozempic brand name has value. MSFT and UNH pretty self explanatory, bought them low and will be forever holds (the shares of UNH I offloaded as I wanted to lower my risk and felt o may have bought them too high, $245 is a price I don't think we'll ever see again but who knows it got close a month ago). ADBE I liked as they keep growing revenue despite the SaaSpocalypse narrative and they are a strong legacy company I feel but again I can't predict the future of this stuff so who knows what AI will do to it. MELI I liked for the Mercado Pago system they have implemented in societies that are still cash reliant where many people don't have traditional bank accounts, and the fact that they are fending off Amazon's e-commerce growth in Latin America, I liked them as a hedge against the U.S. market but they seem more affected by it than I realized. META just makes a ton of money and I bought the dip, don't know if I want to hold them long term as it's really all ad revenue and they don't really provide anything of use to the world beside data centers now I guess. FXAIX and VTI are my index fund/ETF holdings. Hope that answers your question. Thanks for reading
VM what does it look like for LLY earnings?
VM why is LLY getting killed lately
every time i look at LLY and its below 900 i say "i'm buying the dip this time" but then I don't and the next time I look its rocketed back up above 900
**Newbie Portfolio - Any Thoughts?** Hey all - relatively new to actively investing and wanted to reach out as this sub has been super helpful. For context, I'm 25 y/o with a separate 401(k) and IRA (both Roth), and am trying to diversify with a taxable brokerage account. I've created the below allocation for my portfolio, which I hope to grow, contribute, and hold for the next 30-40 years, along with maxing out my IRA/401(k) Realize that it's pretty tech-weighted, but I'm also hoping to be more aggressive, as I have my Roth accounts working for me separately... Would really love any advice or changes that you guys would recommend, as this is all pretty new to me. Thanks so much in advance VXUS 25% QQQM 15% VXF 15% VHT 10% XLE 5% META 5% NVDA 5% AMZN 5% GOOGL 5% TSM 5% LLY 5%
Dip on LLY ahead of earnings in coming weeks seems like a gift. GLP-1s via One Medical/Amazon seems overblown.
All of you might thin why it sudden drop, but for me this is great news The drop is due to the news that Amazon is selling GLP-1 drugs. Basically, any telehealth company that sells GLP-1 is down. However, strangely, NVO and LLY are down as well. Back to the topic: if HIMS is not affected by the news, that means the market believes HIMS doesn’t need to rely on diet-drug revenue. We are totally priced in, even if HIMS is selling fewer and fewer diet pills. Which is great, because I thought the next earnings report would see a pullback because of dropping diet-pill revenue. But the market no longer thinks that’s an issue and is instead focusing on the future of the other product lines, overseas markets, and peptides.
𝐔𝐏𝐃𝐀𝐓𝐄: $AMZN Amazon One Medical Launches GLP-1 Weight Management Program - $LLY $NVO $HIMS 👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: ➤ Amazon launches integrated 𝐆𝐋𝐏-𝟏 weight management program nationwide. ➤ Combines 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐜𝐚𝐫𝐞, pharmacy, and virtual services.
𝐔𝐏𝐃𝐀𝐓𝐄: $AMZN Amazon One Medical Launches GLP-1 Weight Management Program - $LLY $NVO $HIMS 👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: ➤ Amazon launches integrated 𝐆𝐋𝐏-𝟏 weight management program nationwide. ➤ Combines 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐜𝐚𝐫𝐞, pharmacy, and virtual services.
𝐔𝐏𝐃𝐀𝐓𝐄: $AMZN Amazon One Medical Launches GLP-1 Weight Management Program - $LLY $NVO $HIMS 👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: ➤ Amazon launches integrated 𝐆𝐋𝐏-𝟏 weight management program nationwide. ➤ Combines 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐜𝐚𝐫𝐞, pharmacy, and virtual services.
People are not interested in Psychedelics anymore?😆 I thing after 🥭 signed executive order , CMPS, HELP, GHRS are mooning . The question is “ can they compete with ABBV or LLY?”
I hear you on this and you're correct on the financials, but it's not the right way to look at a startup in biopharm. This bet isn't about the financials and trajectory of the standalone company as it's a drug development play. It's a binary event outcome. The ideal outcome is an acquisition by LLY or PFE with a share price around $24 based on similar drugs, TAM, and test trial efficacy. They also have a significant amount of patents that make them a good acquisition target. There is no play here in terms of them turning profitable on their own. This goes to zero if their trail data comes back bad, or $20-40/share in the next 6 months via acquisition.
After this M&A Spree, LLY is going to stock split
Man i hope they split $LLY. This shit trades WAYYYY too thin for this large of a company
$LLY should stock split and see 100% gains again
SEMA is absolute garbage! The worst GLP1 out there. Reta is the future and LLY will have the monopoly on it. It also works for addiction issues and doesn’t eat your muscle mass Ozempic (I.e. SEMA). Retatrutide will be outperform every single weigh-loss solution out there and LLY will at least grow another 50% in the coming years once it’s released.
LLY is so handcuffed by this idea that a pharma company being worth this much doesn’t make sense. It just isn’t that simple anymore. I can’t stop buying.
Why is LLY such a douche, can somebody who does TA tell me it's coiled to spring up or some such
we all joke but AI is genuinely adding real productivity. i genuinely think stocks soar in situations like these because even institutional investors can't price it in very well. It's not even arguable that AI is powerfully augmenting some of the biggest companies in the world, especially ones that can digitally scale with AI, and ones that can't just take longer with analog implementation, like on a robot or tractor Protein folding and drug manufacturing (LLY up ~25% over last year), HALO stocks (caterpillar--i missed all these, but they're all *very* optimistically priced in), and probably materials synthesis soon enough. These companies might literally keep their P/E's way up there. then you got shit like this, OpenAI, allbirds (which, i imagine is the cause of this joke), people just making VSCode forks with just ChatGPT or Claude and slapping different UI on top of it. I really think its genuinely hard for a lot of investors, retail and institutional, to actually know what a good "AI buy" will be, because that shit really works--for some use cases
$LLY option spreads are horrible wtf
My SL triggered and sold my LLY at a loss at 900, fml
LLY LEAPs looking promising....
Healthcare is the next sector to take the AI boom train, dont miss it! Lots of catalysts for $HIMS $NVO $LLY $JNJ $CURE
Anyone know why LLY is dumping?
LLY really pumped to infinity selling peptides you can buy from china for pennies LMAO
I've been in the markets for over 25 years. In my early years, I'd think similar to you and fear my paper gains could evaporate because stock prices do go up and down, a lot. But after some time, I started to realize the same names that always drew my interest kept going up over time. I might a stake here, sell for profit, and buy in later at a higher entry. Point is, if you pick winners, they'll keep going up over time. Look at the long term charts for NVDA AMZN MSFT NFLX GOOGL V WMT LLY COST MA - 100% is nothing. So I'm not sure how deeply you research your stocks or if you just follow hot trends. But if you really want to grow net worth, you want to find "forever" stocks - stocks that consistently increase revenue/profit/distributions over time and have some strong barriers to entry. Of course you also need to keep tracking the stocks in case outlook changes and you may need to liquidate. One way gives you some extra spending cash, other way has potentially life changing gains. TBH - you can just use the index to get 10%/year and double the value roughly every 7 years. When you buy individual stocks, you buy them to hit home runs above the 10%.
I simply do not understand what gives SpaceX a $2T valuation. When u look at all the cos that have $1T+ valuations they have mass market products: the mag 7, avgo, tsmc, tsla, Walmart and not quite but close enough LLY. SpaceX is basically a gov contractor svc for launches and has Starlink which is just a diff form of att/TMobile. How many rockets can u possibly launch or how many cell phones can u link? Computers, cars, cellphones, ads, pills, etc have to be replaced/upgraded time over time...
I've owned LLY for 4 years now and am not selling or adding but it's not a bad deal in the $800's which you might get tomorrow. NVO's not a bad deal in the mid $30's but might require a meaningful amount of patience. Would definitely not own UNH.
You have to think not in terms of being for NVO, but also of being against LLY. I wouldn't bet against LLY
LLY is my #1 position. I'm holding forever unless fundamentals change.
Hi all, I’m currently looking to add either LLY or UNH to my portfolio - to cover my exposure to healthcare. I wanted to get your thoughts on either - do you own one or both? Anything you like with either play? Either would be a longer term hold as opposed to trading it short term. Thanks. Time of posting - LLY $939.03 UNH $304.55
I hold NVO, but this should be expected, healthcare is beat down, politically and financially, legislation is bound to change and all the pricing of healthcare companies is uncertain. NVO provides a solid product, but LLY offers a better one, they are also pioneers of the market, who’s to say another company doesn’t come along within 3-10 years and provide a better product to take the NO2 spot. Also in terms of pharmacy formulary, you can get zeppbound bound for the same cost on tier 3. 2026 guidance is also extremely rough, decreasing rev and tighter margins. It makes sense, but I do think they have a solid product, but it may take until 2027-2028 to see the returns, and they may be small.
Like others have said, when retatrutide hits the market LLY is going to steam roll the competition. Nothing compares to retatrutide! I've used about every drug on the planet during my bodybuilding years and nothing compares to retatrutide.
Because it’s not LLY
They're a good example of why when you have an A grade stock (LLY) and a cheaper B grade stock (NVO), just buy the A stock.
**DId not say anything about timing the market.** My strategy works for me. You many not like it but here it is For my downside strategy, it is simple - if I loses \~15-20% of my original investment dollars, I am out and ask what did I miss or were there any over-riding events (war, terrorism, ..). I will continue to watch but rarely do I average down as I view this as throwing good money after bad. You need to remember if you lose 50%, the stock needs to double just to get to even (that just does not happen often). For the upside (makes sure you have a price target based on your DD and actively monitor), I typically sell 1/3 or 1/4 if it grows 25-50% (no harm in taking profits). If it doubles, I sell half and let the remainder ride as I view these as "free" shares from my original investment dollars. They become part of "hold and forget" portfolio that I only tap if I need the money for a big purchase (car, home remodel, vacation...). Today, my "hold and forget" include HON (\~$30), META ($19), AMD ($2), GE ($6), LLY ($60), BRK.B ($101). HON is my largest individual holding in the high 6-figures today. For my downside strategy, it is simple - if I loses \~15-20% of my original investment dollars, I am out and ask what did I miss or were there any over-riding events (war, terrorism, ..). I will continue to watch but rarely do I average down as I view this as throwing good money after bad. You need to remember if you lose 50%, the stock needs to double just to get to even (that just does not happen often). My most recent addition to my hold and forget portfolio is INTC. - I loaded up on it in the $18-19 range because it assets were greater than it stock value. Slow and steady wins the race. Avoid FOMO and YOLO. Good Luck
at worst it is a 5% divvie stock, at best you make a 2x in a year or two. not wsb material but good enough for me, I loaded around $40. i don't care how better LLY is, or how much cheaper generics are.